Anti-tenascin Monoclonal Antibody 81c6-I-131
Anti-tenascin Monoclonal Antibody 81c6-I-131 Uses, Dosage, Side Effects, Food Interaction and all others data.
Anti-tenascin Monoclonal Antibody 81c6-I-131 is under investigation in clinical trial NCT00615186 (Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy).
| Trade Name | Anti-tenascin Monoclonal Antibody 81c6-I-131 |
| Generic | Neuradiab |
| Neuradiab Other Names | 81c6, a murine igg2 anti-tenascin monoclonal antibody labeled with iodine 131 (I-131), Anti-tenascin monoclonal antibody 81c6-I-131, Iodine i 131 moab 81c6, Iodine i 131 monoclonal antibody 81c6, Iodine I-131 monoclonal antibody 81c6, Moab, 81c6, murine, iodine-I-131 radiolabeled, to human glioma, Neuradiab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Anti-tenascin Monoclonal Antibody 81c6-I-131
